Global Attention Deficit Hyperactivity Disorder (ADHD) Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Attention Deficit Hyperactivity Disorder (ADHD) will have significant change from previous year. According to our latest study, the global Attention Deficit Hyperactivity Disorder (ADHD) market size is USD million in 2022 from USD 11970 million in 2021, with a change of % between 2021 and 2022. The global Attention Deficit Hyperactivity Disorder (ADHD) market size will reach USD 19160 million in 2028, growing at a CAGR of 7.0% over the analysis period.
The United States Attention Deficit Hyperactivity Disorder (ADHD) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Attention Deficit Hyperactivity Disorder (ADHD) market, reaching US$ million by the year 2028. As for the Europe Attention Deficit Hyperactivity Disorder (ADHD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Attention Deficit Hyperactivity Disorder (ADHD) players cover Takeda, Johnson & Johnson, Novartis, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Attention Deficit Hyperactivity Disorder (ADHD) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Stimulant
Non-stimulant
Segmentation by distribution channel: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2017-2028
2.1.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Attention Deficit Hyperactivity Disorder (ADHD) Segment by Type
2.2.1 Stimulant
2.2.2 Non-stimulant
2.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2022)
2.4 Attention Deficit Hyperactivity Disorder (ADHD) Segment by Distribution Channel
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
2.5.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028)
2.5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2022)
3 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Player
3.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Players
3.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2020-2022)
3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Players (2020-2022)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Attention Deficit Hyperactivity Disorder (ADHD) by Regions
4.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Regions (2017-2022)
4.2 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2017-2022)
4.3 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2017-2022)
4.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2017-2022)
4.5 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022)
5.2 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
5.3 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2017-2022)
6.2 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
6.3 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) by Country (2017-2022)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) by Region (2017-2022)
8.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022)
8.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Regions (2023-2028)
10.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Regions (2023-2028)
10.1.2 Americas Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.1.3 APAC Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.1.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.1.5 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.2 Americas Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Country (2023-2028)
10.2.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.2.2 Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.2.3 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.2.4 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.3 APAC Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Region (2023-2028)
10.3.1 China Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.3.2 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.3.3 Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.3.4 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.3.5 India Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.3.6 Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Country (2023-2028)
10.4.1 Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.4.2 France Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.4.3 UK Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.4.4 Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.4.5 Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.5 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Region (2023-2028)
10.5.1 Egypt Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.5.2 South Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.5.3 Israel Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.5.4 Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.5.5 GCC Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.6 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Type (2023-2028)
10.7 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Distribution Channel (2023-2028)
11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Tris Pharma
11.5.1 Tris Pharma Company Information
11.5.2 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Tris Pharma Main Business Overview
11.5.5 Tris Pharma Latest Developments
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Information
11.6.2 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Neos Therapeutics Main Business Overview
11.6.5 Neos Therapeutics Latest Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Information
11.7.2 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mallinckrodt Main Business Overview
11.7.5 Mallinckrodt Latest Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Information
11.8.2 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Amneal Pharmaceuticals Main Business Overview
11.8.5 Amneal Pharmaceuticals Latest Developments
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Information
11.9.2 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Noven Pharmaceuticals Main Business Overview
11.9.5 Noven Pharmaceuticals Latest Developments
11.10 Purdue Parma
11.10.1 Purdue Parma Company Information
11.10.2 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Purdue Parma Main Business Overview
11.10.5 Purdue Parma Latest Developments
11. CTFH
11.11.1 CTFH Company Information
11.11.2 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 CTFH Main Business Overview
11.11.5 CTFH Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Stimulant
Table 3. Major Players of Non-stimulant
Table 4. Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2022)
Table 7. Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2022)
Table 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Player (2020-2022)
Table 12. Attention Deficit Hyperactivity Disorder (ADHD) Key Players Head office and Products Offered
Table 13. Attention Deficit Hyperactivity Disorder (ADHD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Regions (2017-2022)
Table 18. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Country (2017-2022)
Table 20. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2022)
Table 22. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 23. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2022)
Table 24. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Region (2017-2022)
Table 26. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2022)
Table 28. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 29. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2022)
Table 30. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Country (2017-2022)
Table 32. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2022)
Table 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2022)
Table 36. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Attention Deficit Hyperactivity Disorder (ADHD)
Table 43. Key Market Challenges & Risks of Attention Deficit Hyperactivity Disorder (ADHD)
Table 44. Key Industry Trends of Attention Deficit Hyperactivity Disorder (ADHD)
Table 45. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Forecast by Distribution Channel (2023-2028) & ($ Millions)
Table 50. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share Forecast by Distribution Channel (2023-2028)
Table 51. Takeda Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 52. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 53. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Takeda Main Business
Table 55. Takeda Latest Developments
Table 56. Johnson & Johnson Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 57. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 58. Johnson & Johnson Main Business
Table 59. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Johnson & Johnson Latest Developments
Table 61. Novartis Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 62. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Novartis Latest Developments
Table 66. Eli Lilly Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 67. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 68. Eli Lilly Main Business
Table 69. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Eli Lilly Latest Developments
Table 71. Tris Pharma Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 72. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 73. Tris Pharma Main Business
Table 74. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Tris Pharma Latest Developments
Table 76. Neos Therapeutics Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 77. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 78. Neos Therapeutics Main Business
Table 79. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Neos Therapeutics Latest Developments
Table 81. Mallinckrodt Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 82. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 83. Mallinckrodt Main Business
Table 84. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Mallinckrodt Latest Developments
Table 86. Amneal Pharmaceuticals Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 87. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 88. Amneal Pharmaceuticals Main Business
Table 89. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Amneal Pharmaceuticals Latest Developments
Table 91. Noven Pharmaceuticals Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 92. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 93. Noven Pharmaceuticals Main Business
Table 94. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Noven Pharmaceuticals Latest Developments
Table 96. Purdue Parma Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 97. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 98. Purdue Parma Main Business
Table 99. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Purdue Parma Latest Developments
Table 101. CTFH Details, Company Type, Attention Deficit Hyperactivity Disorder (ADHD) Area Served and Its Competitors
Table 102. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
Table 103. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. CTFH Main Business
Table 105. CTFH Latest Developments
List of Figures
Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type in 2021
Figure 7. Attention Deficit Hyperactivity Disorder (ADHD) in Hospital Pharmacy
Figure 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Attention Deficit Hyperactivity Disorder (ADHD) in Retail Pharmacy
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel in 2021
Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Player in 2021
Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2017-2022 ($ Millions)
Figure 15. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2017-2022 ($ Millions)
Figure 16. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2017-2022 ($ Millions)
Figure 18. Americas Attention Deficit Hyperactivity Disorder (ADHD) Value Market Share by Country in 2021
Figure 19. Americas Attention Deficit Hyperactivity Disorder (ADHD) Consumption Market Share by Type in 2021
Figure 20. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel in 2021
Figure 21. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Region in 2021
Figure 26. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel in 2021
Figure 27. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Country in 2021
Figure 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type in 2021
Figure 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel in 2021
Figure 36. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel in 2021
Figure 44. Egypt Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 50. APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 51. Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 53. United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 54. Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 57. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 58. Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 59. Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 61. India Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 62. Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 63. Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 64. France Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 65. UK Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 66. Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 67. Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 68. Spain Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 71. Israel Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2023-2028 ($ Millions)
